FDA Inspection
Orion Corporation, Orion PharmaOrion Corporation, Orion Pharma – FDA Inspection, Apr 21, 2017
Record Details
This FDA Inspection record concerns Orion Corporation, Orion Pharma, with an inspection on April 21, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 9cab18cd-831f-49af-8be8-260958df5255
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1012832
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
Other FDA inspections of Orion Corporation, Orion Pharma
8| Date | Classification | Office | Project area |
|---|---|---|---|
| November 7, 2024 | Not classified | Office of Inspections and Investigations | |
| June 2, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 17, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 1, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 13, 2016 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
Other documents for Orion Corporation, Orion Pharma
- FDA Inspection 1310408 - 2024-11-07
- FDA Inspection 1218973 - 2022-06-02
- FDA Inspection 1156118 - 2020-09-17
- FDA Inspection 1053840 - 2018-06-01
- FDA Inspection 987011 - 2016-09-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.